Vanflyta Now Available for FLT3-ITD Positive Acute Myeloid Leukemia
Vanflyta is available only through a risk evaluation and mitigation strategy program.
Vanflyta is available only through a risk evaluation and mitigation strategy program.
LGBTQ+ adolescents and young adults with cancer face unique challenges in the health care setting, a review suggests.
Certain factors may increase the risk of severe COVID-19 in patients with cancer, research suggests.
New research suggests that a mobile app may help patients with multiple myeloma or chronic lymphocytic leukemia manage their symptoms.
SeekInCare, a blood-based multi-cancer detection test, can detect more than 20 cancer types with high specificity, according to researchers.
As many as 55% of patients with cancer may be affected by food insecurity.
Engaging in vigorous physical activity for 3 to 4 minutes per day is associated with a decrease in the risk of cancer among adults who typically don’t exercise, new research suggests.
Housing insecurity can impede patients’ access to cancer screening, treatment, and survivorship care, increasing the risk of poor outcomes.
Researchers have estimated that failed oncology trials cost about $50 billion to $60 billion each year.
Cancer patients may be particularly susceptible to transportation-related disruptions in care.